These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38907706)

  • 1. Cost-effectiveness Analysis of Colorectal Cancer Screening Strategies Using Active Learning and Monte Carlo Simulation.
    Fouladi A; Asadi A; Sherer EA; Madadi M
    Med Decis Making; 2024 Jul; 44(5):554-571. PubMed ID: 38907706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Effectiveness and Cost Effectiveness of a Multitarget Stool DNA Test to Screen for Colorectal Neoplasia.
    Ladabaum U; Mannalithara A
    Gastroenterology; 2016 Sep; 151(3):427-439.e6. PubMed ID: 27311556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening for Colorectal Cancer With Fecal Immunochemical Testing With and Without Postpolypectomy Surveillance Colonoscopy: A Cost-Effectiveness Analysis.
    Greuter MJE; de Klerk CM; Meijer GA; Dekker E; Coupé VMH
    Ann Intern Med; 2017 Oct; 167(8):544-554. PubMed ID: 28973514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness and budget impact analyses of colorectal cancer screenings in a low- and middle-income country: example from Thailand.
    Phisalprapa P; Supakankunti S; Chaiyakunapruk N
    J Med Econ; 2019 Dec; 22(12):1351-1361. PubMed ID: 31560247
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness analysis of single colonoscopy versus single fecal test for colorectal cancer diagnosis and treatment.
    Ishibashi F; Suzuki S; Kobayashi K; Tanaka R; Kawakami T; Mochida K; Nagai M; Ishibashi Y; Morishita T
    J Gastroenterol Hepatol; 2024 Jul; 39(7):1328-1335. PubMed ID: 38348570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cost-effectiveness analysis of colorectal cancer screening using colonoscopy, fecal immunochemical test, and risk score.
    Sekiguchi M; Igarashi A; Sakamoto T; Saito Y; Esaki M; Matsuda T
    J Gastroenterol Hepatol; 2020 Sep; 35(9):1555-1561. PubMed ID: 32167186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of new non-invasive tests for colorectal cancer screening: the relevance of information on adenoma detection.
    Haug U; Knudsen AB; Lansdorp-Vogelaar I; Kuntz KM
    Int J Cancer; 2015 Jun; 136(12):2864-74. PubMed ID: 25403937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening Under Commercial Insurance vs. Medicare.
    Ladabaum U; Mannalithara A; Brill JV; Levin Z; Bundorf KM
    Am J Gastroenterol; 2018 Dec; 113(12):1836-1847. PubMed ID: 29904156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal use of colonoscopy and fecal immunochemical test for population-based colorectal cancer screening: a cost-effectiveness analysis using Japanese data.
    Sekiguchi M; Igarashi A; Matsuda T; Matsumoto M; Sakamoto T; Nakajima T; Kakugawa Y; Yamamoto S; Saito H; Saito Y
    Jpn J Clin Oncol; 2016 Feb; 46(2):116-25. PubMed ID: 26685321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With Blood-Based Biomarkers (Liquid Biopsy) vs Fecal Tests or Colonoscopy.
    Ladabaum U; Mannalithara A; Weng Y; Schoen RE; Dominitz JA; Desai M; Lieberman D
    Gastroenterology; 2024 Jul; 167(2):378-391. PubMed ID: 38552670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population health outcomes of blood-based screening for colorectal cancer in comparison to current screening modalities: insights from a discrete-event simulation model incorporating longitudinal adherence.
    Forbes SP; Yay Donderici E; Zhang N; Sharif B; Tremblay G; Schafer G; Raymond VM; Talasaz A; Eagle C; Das AK; Grady WM
    J Med Econ; 2024; 27(1):991-1002. PubMed ID: 39037853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness and Cost-Effectiveness of Colorectal Cancer Screening With a Blood Test That Meets the Centers for Medicare & Medicaid Services Coverage Decision.
    van den Puttelaar R; Nascimento de Lima P; Knudsen AB; Rutter CM; Kuntz KM; de Jonge L; Escudero FA; Lieberman D; Zauber AG; Hahn AI; Inadomi JM; Lansdorp-Vogelaar I
    Gastroenterology; 2024 Jul; 167(2):368-377. PubMed ID: 38552671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Multitarget Stool DNA Testing vs Colonoscopy or Fecal Immunochemical Testing for Colorectal Cancer Screening in Alaska Native People.
    Redwood DG; Dinh TA; Kisiel JB; Borah BJ; Moriarty JP; Provost EM; Sacco FD; Tiesinga JJ; Ahlquist DA
    Mayo Clin Proc; 2021 May; 96(5):1203-1217. PubMed ID: 33840520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
    Sonnenberg A; Delcò F; Inadomi JM
    Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of Increasing Access to Colorectal Cancer Diagnosis: Analysis From Thailand.
    Wongseree P; Hasgul Z; Jalali MS
    Value Health Reg Issues; 2024 Sep; 43():101010. PubMed ID: 38848611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
    Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
    Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-Effectiveness and National Effects of Initiating Colorectal Cancer Screening for Average-Risk Persons at Age 45 Years Instead of 50 Years.
    Ladabaum U; Mannalithara A; Meester RGS; Gupta S; Schoen RE
    Gastroenterology; 2019 Jul; 157(1):137-148. PubMed ID: 30930021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness modeling of colorectal cancer: computed tomography colonography vs colonoscopy or fecal occult blood tests.
    Lucidarme O; Cadi M; Berger G; Taieb J; Poynard T; Grenier P; Beresniak A
    Eur J Radiol; 2012 Jul; 81(7):1413-9. PubMed ID: 21444171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic evaluation of screening for colorectal cancer: Case of Iran.
    Barouni M; Ghaderi H; Shahmoradi MK
    Clin Lab; 2013; 59(5-6):667-74. PubMed ID: 23865368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic evaluation of colorectal cancer screening programs: Affordability for the health service.
    Coretti S; Ruggeri M; Dibidino R; Gitto L; Marcellusi A; Mennini FS; Cicchetti A
    J Med Screen; 2020 Dec; 27(4):186-193. PubMed ID: 31948342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.